Skip to main content

09-30-2021 | EASD 2021 | Conference coverage | News

Insulin resistance linked to arterial stiffness in type 1 diabetes

Author: Claire Barnard


medwireNews: Researchers have identified an association between insulin resistance (IR) and arterial stiffness among people with type 1 diabetes.

Speaking at the virtual 57th EASD Annual Meeting, Gemma Llauradó (Institut Hospital del Mar d'Investigacions Mèdiques, Barcelona, Spain) explained that while “insulin deficiency is the main pathogenic factor in type 1 diabetes,” people with the disease can also have clinical features of IR, in a condition termed “double diabetes.”

She added that the presence of IR is associated with an elevated risk for micro- and macrovascular complications in people with type 1 diabetes.

To investigate the hypothesis that IR in the arterial wall could promote arterial stiffness “through several mechanisms,” including vasoconstriction, inflammation, and oxidative stress, the team analyzed data from 179 adults with type 1 diabetes and no prior cardiovascular disease. The study cohort was categorized into quartiles based on IR, which was measured by the estimated glucose disposal rate (eGDR).

Llauradó reported that there was a significant trend for the association between IR and arterial stiffness as measured by average aortic pulse wave velocity (aPWV), with a correlation coefficient of 0.59. People in the lowest quartile of eGDR (<6.1 mg/kg per min) – indicating the highest level of IR – had the greatest degree of arterial stiffness, with an aPWV of 8.3 m/s. This decreased with increasing quartiles of eGDR, to 6.1 m/s for the highest quartile (>10 mg/kg per min).

In a multivariate analysis using the highest eGDR quartile as the reference group, people in the lowest two quartiles had significantly greater aPWV, indicating greater arterial stiffness, after adjustment for traditional cardiovascular risk factors including age, sex, diabetes duration, and dyslipidemia.

“Thus, insulin resistance [is] one of the main independent factors associated with increase of arterial stiffness,” said Llauradó.

She said that the key variable explaining this association “seemed to be abdominal obesity instead of glycemic control or hypertension.” Indeed, when components of the equation used to calculate eGDR were analyzed separately in the multivariate analysis, only waist-to-hip ratio was significantly associated with aPWV.

medwireNews is an independent medical news service provided by Springer Healthcare Ltd. © 2021 Springer Healthcare Ltd, part of the Springer Nature Group

EASD Annual Meeting; Sept 27–Oct 1, 2021


Novel clinical evidence in continuous glucose monitoring

Novel clinical evidence in continuous glucose monitoring

How real-world studies complement randomized controlled trials

Jean-Pierre Riveline uses data from real-life continuous glucose monitoring studies to illustrate how these can uncover critical information about clinical outcomes that are hard to assess in randomized controlled trials.

This video has been developed through unrestricted educational funding from Abbott Diabetes Care.

Watch the video